Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

McDonald's delivers mixed Q1 results

(Sharecast News) - Fast food giant McDonald's delivered mixed first-quarter results on Tuesday as restructuring costs weighed on profits. McDonald's reported a Q1 net income of $1.93bn, or $2.66 on a per share basis, up from $1.8bn a year earlier. However, a pre-tax charge of $35.0m linked to its reorganisation efforts weighed on earnings. Excluding restructuring charges, McDonald's earned $2.70 per share.

Net sales rose 5% to $6.17bn, with global same-store sales increasing 1.9% in the quarter, falling short of estimates of 2.1% growth. US same-store sales grew of 2.5%, missing expectations of 2.6%. McDonald's said average transaction values grew due to increased menu prices but also seemingly deterred low-income customers as a result of its hiked prices.

"Consumers continue to be even more discriminating with every dollar that they spend as they faced elevated prices in their day-to-day spending, which is putting pressure on the industry," said chief executive Chris Kempczinski, who added that McDonald's now has to be "laser focused" on affordability if it wants to attract diners.

Demand in the company's international developmental licensed markets was weak, with same-store sales falling 0.2%, marking the first time since Covid-19 that one of its divisions posted a same-store sales decline. Worth noting, the segment includes its Middle East operations, which have experienced boycotts after a McDonald's Israeli licensee offered discounts to soldiers. Earlier in April, McDonald's purchased 225 restaurants operated by its Israeli franchisee.

As of 1450 BST, McDonald's shares were down 1.34% at $269.74 each.

Reporting by Iain Gilbert at Sharecast.com

Share this article

Related Sharecast Articles

Hutchmed publishes positive sovleplenib trial results
(Sharecast News) - Hutchmed China announced the publication of positive results from its phase three 'ESLIM-01' trial of sovleplenib in the Lancet Haematology.
Somero trading in line with expectations
(Sharecast News) - Somero Enterprises said in an update on Monday that trading for the first five months of 2024 was consistent with expectations.
Aptitude inks three-year deal with US insurance brokerage
(Sharecast News) - Financial software solutions provider Aptitude Software announced a significant contract win with a prominent multibillion-dollar insurance brokerage in the United States on Monday.
Picton Property reports solid asset management progress
(Sharecast News) - Picton Property Income announced significant developments in its asset management strategy on Monday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.